What is LOPJLB’s current signal on EWTX?

LOPJLB’s latest quantitative signal on Edgewise Therapeutics, Inc. (EWTX) is SELL in a BEAR regime. Signals are updated daily.

What market regime is EWTX in?

Edgewise Therapeutics, Inc. (EWTX) is currently classified in the BEAR HMM market regime on LOPJLB.

What does Edgewise Therapeutics, Inc. (EWTX) do?

Edgewise Therapeutics, Inc. is a biopharmaceutical firm dedicated to developing small-molecule treatments for a range of musculoskeletal disorders. Its leading investigational drug, EDG-5506, is an orally administered compound specifically engineered to tackle the fundamental genetic causes of dystrophinopathies, including Duchenne and Becker muscular dystrophy. This candidate has successfully …

Where is Edgewise Therapeutics, Inc. based / listed?

Edgewise Therapeutics, Inc. is based in US, listed on NASDAQ.

Edgewise Therapeutics, Inc. (EWTX)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$39.23-0.86%Close

SELLBEAR · day 7

[SCORES & PROFILE]

FUND: 19
VALUE: 8
GROWTH: 47
GARP: 6
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC-23.4%

REV YoY-

ROE-39.0%

EPS YoY-

ROA-41.1%

GROSS

NET

[VALUATION]

P/E TTM-21.63

P/E FWD-

SECTOR PE20.12

INDUSTRY PE13.79

P/B9.62

P/FCF-

EV/EBITDA-21.49

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E0.80

ALTMAN Z-

CURR RATIO16.24

ND/EBITDA-

BETA0.28

Edgewise Therapeutics, Inc. (EWTX)

Key stats

Industry peers

Prediction markets

FUNDAMENTALS

Company news